Kamran Alam
2017 - Aquinox Pharmaceuticals
In 2017, Kamran Alam earned a total compensation of $1.4M as Chief Financial Officer and Vice President, Finance at Aquinox Pharmaceuticals, a 147% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,525 |
|---|---|
| Option Awards | $989,984 |
| Salary | $335,000 |
| Total | $1,430,509 |
Alam received $990K in option awards, accounting for 69% of the total pay in 2017.
Alam also received $105.5K in non-equity incentive plan and $335K in salary.
Rankings
In 2017, Kamran Alam's compensation ranked 7,236th out of 14,666 executives tracked by ExecPay. In other words, Alam earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,236 out of 14,666 | 51st |
Division Manufacturing | 2,690 out of 5,768 | 53rd |
Major group Chemicals And Allied Products | 879 out of 2,074 | 58th |
Industry group Drugs | 687 out of 1,730 | 60th |
Industry Pharmaceutical Preparations | 540 out of 1,329 | 59th |
Source: SEC filing on March 26, 2018.
Alam's colleagues
We found two more compensation records of executives who worked with Kamran Alam at Aquinox Pharmaceuticals in 2017.
News
Taysha Gene Therapies CEO Sean Nolan's 2023 pay slips 20% to $1.5M
April 18, 2024
Taysha Gene Therapies CEO RA Session's 2022 pay falls 57% to $2M
May 8, 2023
Taysha Gene Therapies CEO RA Session's 2021 pay slips 3% to $4.6M
April 28, 2022
Inotek Pharmaceuticals CEO Gaurav Shah's 2019 pay falls 39% to $3.9M
April 24, 2020
Aquinox Pharmaceuticals CEO Jonathan Drachman receives $3.8M in 2019
March 24, 2020
Aquinox Pharmaceuticals CEO David Main's 2018 pay jumps 39% to $4.2M
October 2, 2019